R. On

Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan

M. Fujita, H. Kushima, Takemasa Matsumoto, 2020, Respiratory Investigation.

Two cases of pleuroparenchymal fibroelastosis diagnosed with transbronchial lung biopsy

M. Fujita, Y. Kinoshita, H. Ishii, 2016, Respiratory medicine case reports.

Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial

M. Fujita, K. Takayama, J. Uchino, 2018, Investigational New Drugs.

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan

M. Fujita, Takemasa Matsumoto, Kentaro Watanabe, 2018, International journal of chronic obstructive pulmonary disease.

Days of Antibiotic Spectrum Coverage Trends and Assessment in Patients with Bloodstream Infections: A Japanese University Hospital Pilot Study

I. Tokimatsu, Kaho Yamada, Takahiro Takuma, 2022, Antibiotics.

TNFR1 Mediated Apoptosis Is Protective against Mycobacterium avium in Mice

M. Fujita, H. Ouchi, Y. Shundo, 2023, Microorganisms.

Endobronchial Lipoma: The Diagnostic Benefit of Computed Tomography Findings

H. Ishii, H. Kushima, Kentaro Watanabe, 2017, Internal medicine.

Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

M. Fujita, T. Harada, Takato Ikeda, 2023, AntiCancer Research.

Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

M. Fujita, T. Harada, Takato Ikeda, 2023, AntiCancer Research.